Suppr超能文献

一种用于加强和指导亚洲整体姑息治疗的新型家庭尊严干预措施(FDI):一项随机对照试验的研究方案。

A novel Family Dignity Intervention (FDI) for enhancing and informing holistic palliative care in Asia: study protocol for a randomized controlled trial.

作者信息

Ho Andy Hau Yan, Car Josip, Ho Moon-Ho Ringo, Tan-Ho Geraldine, Choo Ping Ying, Patinadan Paul Victor, Chong Poh Heng, Ong Wah Ying, Fan Gilbert, Tan Yee Pin, Neimeyer Robert A, Chochinov Harvey M

机构信息

Psychology, School of Social Sciences, Nanyang Technological University, 14 Nanyang Drive, HSS-04-03, Singapore, 637332, Singapore.

Centre for Population Health Sciences, Lee Kong Chian School of Medicine, Nanyang Technological University, 11 Mandalay Road, Level 18, Clinical Science Building, Singapore, 308232, Singapore.

出版信息

Trials. 2017 Dec 4;18(1):587. doi: 10.1186/s13063-017-2325-5.

Abstract

BACKGROUND

The lack of a holistic approach to palliative care can lead to a fractured sense of dignity at the end of life, resulting in depression, hopelessness, feelings of being a burden to others, and the loss of the will to live among terminally ill patients. Building on the clinical foundation of Dignity Therapy, together with the empirical understanding of dignity-related concerns of Asian families facing terminal illness, a novel Family Dignity Intervention (FDI) has been developed for Asian palliative care. FDI comprises a recorded interview with a patient and their primary family caregiver, which is transcribed, edited into a legacy document, and returned to the dyads for sharing with the rest of the patient's family. The aims of this study are to assess the feasibility, acceptability and potential effectiveness of FDI in reducing psychosocial, emotional, spiritual, and psychophysiological distress in community-dwelling and in-patient, Asian, older terminally ill patients and their families living in Singapore.

METHODS/DESIGN: An open-label randomized controlled trial. One hundred and twenty-six patient-family dyads are randomly allocated to one of two groups: (1) an intervention group (FDI offered in addition to standard psychological care) and (2) a control group (standard psychological care). Both quantitative and qualitative outcomes are assessed in face-to-face interviews at baseline, 3 days and 2 weeks after intervention, as well as during an exit interview with family caregivers at 2 months post bereavement. Primary outcome measures include sense of dignity for patients and psychological distress for caregivers. Secondary outcomes include meaning in life, quality of life, spirituality, hopefulness, perceived support, and psychophysiological wellbeing, as well as bereavement outcomes for caregivers. Qualitative data are analyzed using the Framework method.

DISCUSSION

To date, there is no available palliative care intervention for dignity enhancement in Asia. This first-of-its-kind study develops and tests an evidence-based, family driven, psycho-socio-spiritual intervention for enhancing dignity and wellbeing among Asian patients and families facing mortality. It addresses a critical gap in the provision of holistic palliative care. The expected outcomes will contribute to advancements in both theories and practices of palliative care for Singapore and its neighboring regions while serving to inform similar developments in other Asian communities.

TRIAL REGISTRATION

ClinicalTrials.gov, ID: NCT03200730 . Registered on 26 June 2017.

摘要

背景

缺乏整体的姑息治疗方法可能导致临终时尊严感的破碎,从而致使晚期患者出现抑郁、绝望、感觉成为他人负担以及失去生存意志等情况。基于尊严疗法的临床基础,结合对面临绝症的亚洲家庭尊严相关问题的实证理解,已为亚洲姑息治疗开发了一种新型的家庭尊严干预措施(FDI)。FDI包括对患者及其主要家庭照顾者进行的一次录音访谈,访谈内容会被转录、编辑成一份遗愿文件,然后返还给这两人以便与患者家庭的其他成员分享。本研究的目的是评估FDI在减轻居住在新加坡的社区及住院的亚洲老年晚期患者及其家庭的心理社会、情感、精神和心理生理痛苦方面的可行性、可接受性及潜在效果。

方法/设计:一项开放标签随机对照试验。126对患者-家庭被随机分配到两组之一:(1)干预组(除标准心理护理外还提供FDI)和(2)对照组(标准心理护理)。在基线、干预后3天和2周的面对面访谈中,以及在丧亲后2个月与家庭照顾者的退出访谈中评估定量和定性结果。主要结局指标包括患者的尊严感和照顾者的心理痛苦。次要结局包括生活意义、生活质量、精神性、希望感、感知到的支持和心理生理幸福感,以及照顾者的丧亲结局。定性数据采用框架法进行分析。

讨论

迄今为止,亚洲尚无用于增强尊严的姑息治疗干预措施。这项首创的研究开发并测试了一种基于证据、以家庭为驱动的心理社会精神干预措施,以提高面临死亡的亚洲患者及其家庭的尊严和幸福感。它填补了提供整体姑息治疗方面的一个关键空白。预期结果将有助于推动新加坡及其周边地区姑息治疗理论和实践的进步,同时为其他亚洲社区的类似发展提供参考。

试验注册

ClinicalTrials.gov,标识符:NCT03200730。于2017年6月26日注册。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/47be/5715529/955026f50aaf/13063_2017_2325_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验